Ji, Y <br/><br/>
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jan 2011 
 - 97-104 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2010.250  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Pharmacological--blood<br/>Cell Line<br/>Chromosomes, Human, Pair 9--genetics<br/>Citalopram--therapeutic use<br/>DNA-Binding Proteins--metabolism<br/>Depressive Disorder, Major--blood<br/>Drug Monitoring--methods<br/>Female<br/>Genetic Association Studies<br/>Glycine--blood<br/>Glycine Dehydrogenase (Decarboxylating)--genetics<br/>Humans<br/>Introns--genetics<br/>Linkage Disequilibrium<br/>Male<br/>Metabolome--drug effects<br/>Nuclear Proteins--metabolism<br/>Polymorphism, Single Nucleotide<br/>Selective Serotonin Reuptake Inhibitors--therapeutic use